ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselBeOne Medicines I GmbH
BeOne Medicines I GmbH Logo
Verified· 3 sourcesTrust Score
Summary

About the company

BeOne Medicines I GmbH researches, develops and commercializes oncology medicines and runs global clinical trials across hematologic and solid tumor indications; publicly referenced products include zanubrutinib (BRUKINSA), tislelizumab (TEVIMBRA) and pamiparib.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

BeOne Medicines I GmbH

✓ Offered5
Oncology research and development
Oncology research and development, pipeline for haematological cancers and solid tumours, clinical studies, collaboration with researchers and care providers to develop cancer therapies.
Cancer medicines
Cancer medicines for various tumour types, including haematological cancers and solid tumours; information on the active ingredient and product pipeline as well as on approved and in-development therapies.
Clinical trials
Clinical trials, trial information for patients, healthcare professionals and researchers, investigator-initiated trial as well as support for investigators and HCP networks.
Patient support
Patient support, expanded access programmes, patient safety and information-related offerings for people with cancer as well as for their caregivers.
Medical information
Medical information for specialist audiences and other target groups, with a standalone information portal and contact points for medical enquiries.
Trust & reputation

ranQ Trust Score of BeOne Medicines I GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

BeOne Medicines I GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
BeOne Medicines I GmbH scores 82.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
BeOne Medicines I GmbH scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
BeOne Medicines I GmbH scores 60.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.20.04%
Qualifications+0.00

BeOne Medicines I GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

May 27, 2025Media
Pharmaunternehmen BeOne verlegt seinen Sitz nach Basel
srf.ch

Knowledge

No knowledge articles yet

Once BeOne Medicines I GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

BeOne Medicines I GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BeOne Medicines I GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BeOne Medicines I GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aeschengraben 27
4051 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-151.848.099
Founded
2017 · 9 years
Last commercial register change
September 21, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    LB
    Luzsana Biotechnology Europe AG
    Basel
    US
    Urovant Sciences GmbH
    Basel
    RM
    Revolution Medicines Switzerland GmbH
    Basel
    AS
    Autolus Switzerland AG
    Basel
    TG
    Taysha Gene Therapies Switzerland GmbH
    Basel
    NP
    Novartis Pharma AG
    Basel
    BI
    Boehringer Ingelheim (Schweiz) GmbH
    Basel
    RS
    Regeneron Switzerland GmbH
    Basel